Britannia Pharmaceuticals Ltd is a UK-based, privately-owned speciality pharmaceutical company established in 1981. The company operates as a limited company with a registered number of 01557088. Britannia focuses on the development, manufacture, and commercialization of innovative treatments for Parkinson’s disease and schizophrenia. Currently, the company’s core business centers around providing pharmaceutical products to patients and healthcare professionals globally. Britannia specializes in complex formulations and delivery systems designed to enhance the efficacy and patient experience of these therapies. The company’s strategic focus is on delivering high-quality, differentiated medicines addressing significant unmet medical needs. Britannia’s international presence is actively pursued through strategic partnerships and distribution networks, with a growing emphasis on expanding its reach into key markets. As a Skilled Worker visa holder, Britannia Pharmaceuticals employs a team of dedicated professionals, and the company is actively engaged in hiring initiatives. The company’s key industry focus is pharmaceutical goods, with a strong emphasis on specialized therapeutic areas. SIC codes include - 46460: Wholesale of pharmaceutical goods, and the company’s website data indicates a significant international presence.

Britannia Pharmaceuticals Ltd is a UK-based, privately-owned speciality pharmaceutical company established in 1981. The company operates as a limited company with a registered number of 01557088. Britannia focuses on the development, manufacture, and commercialization of innovative treatments for Parkinson’s disease and schizophrenia. Currently, the company’s core business centers around providing pharmaceutical products to patients and healthcare professionals globally. Britannia specializes in complex formulations and delivery systems designed to enhance the efficacy and patient experience of these therapies. The company’s strategic focus is on delivering high-quality, differentiated medicines addressing significant unmet medical needs. Britannia’s international presence is actively pursued through strategic partnerships and distribution networks, with a growing emphasis on expanding its reach into key markets. As a Skilled Worker visa holder, Britannia Pharmaceuticals employs a team of dedicated professionals, and the company is actively engaged in hiring initiatives. The company’s key industry focus is pharmaceutical goods, with a strong emphasis on specialized therapeutic areas. SIC codes include - 46460: Wholesale of pharmaceutical goods, and the company’s website data indicates a significant international presence.